Knight Therapeutics Inc. (KHTRF) Stock Overview
Explore Knight Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.
Knight Therapeutics Inc. (KHTRF)
Key Financials
Key Financials
Market Cap
599M
P/E Ratio
153.08
EPS (TTM)
$0.04
ROE
0.01%
KHTRF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Knight Therapeutics Inc. (KHTRF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.63.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 153.08 and a market capitalization of 599M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.